Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Filaments citoplasmàtics"'
Autor:
Elias S. Sotirchos, Kathryn C. Fitzgerald, Carol M. Singh, Matthew D. Smith, Maria Reyes‐Mantilla, Carrie M. Hersh, Megan H. Hyland, Ryan Canissario, Sarah B. Simmons, Georgina Arrambide, Xavier Montalban, Manuel Comabella, Robert T. Naismith, Min Qiao, Lauren B. Krupp, Jacqueline A. Nicholas, Katja Akgün, Tjalf Ziemssen, Richard Rudick, Elizabeth Fisher, Robert A. Bermel, Ellen M. Mowry, Peter A. Calabresi
Publikováno v:
Scientia
Esclerosi múltiple; Cadena lleugera de neurofilaments sèrics Esclerosis múltiple; Cadena ligera de neurofilamentos séricos Multiple sclerosis; Serum neurofilament light chain Objective Evaluation of serum neurofilament light chain (sNfL), measure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bf463c953af25086d8f483cbbaa74aa
https://doi.org/10.1002/acn3.51704
https://doi.org/10.1002/acn3.51704
Autor:
Bar-Or, Amit, Montalban, Xavier, Hu, Xixi, Kropshofer, Harald, Kukkaro, Petra, Coello, Neva, Ludwig, Inga, Willi, Roman, Zalesak, Martin, Ramanathan, Krishnan, Kieseier, Bernd C., Häring, Dieter A., Bagger, Morten, Fox, Edward, Universitat Autònoma de Barcelona
Publikováno v:
Scientia
Biomarker; Ofatumumab; Relapsing multiple sclerosis Biomarcador; Ofatumumab; Esclerosis múltiple recurrente Biomarcador; Ofatumumab; Esclerosi múltiple recurrent Introduction Several studies have described prognostic value of serum neurofilament li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80586cc727bc203517709ef89bedb5cb
https://ddd.uab.cat/record/275799
https://ddd.uab.cat/record/275799
Publikováno v:
Brain
Scientia
Scientia
Multiple sclerosis is a highly heterogeneous disease, and the detection of neuroaxonal damage as well as its quantification is a critical step for patients. Blood-based serum neurofilament light chain (sNfL) is currently under close investigation as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f989a94f437c402ca2a1ad55039f8fa
https://doi.org/10.1093/brain/awab241
https://doi.org/10.1093/brain/awab241
Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab
Autor:
Fissolo, Nicolás, Pignolet, Beatrice, Rio, Jordi, Vermersch, Patrick, Ruet, Aurélie, deSèze, Jerome, Labauge, Pierre, Vukusic, Sandra, Papeix, Caroline, Martinez-Almoyna, Laurent, Tourbah, Ayman, Clavelou, Pierre, Moreau, Thibault, Pelletier, Jean, Lebrun-Frenay, Christine, Bourre, Bertrand, Defer, Gilles, Montalban, Xavier, Brassat, David, Comabella, Manuel, Universitat Autònoma de Barcelona
Publikováno v:
Neurology Neuroimmunology & Neuroinflammation
Neurology Neuroimmunology & Neuroinflammation, American Academy of neurology, 2021, 8 (4), pp.e1003. ⟨10.1212/NXI.0000000000001003⟩
Neurology Neuroimmunology & Neuroinflammation, 2021, 8 (4), pp.e1003. ⟨10.1212/NXI.0000000000001003⟩
Scientia
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Neurology® Neuroimmunology & Neuroinflammation
article-version (Version of Record) 3
Neurology Neuroimmunology & Neuroinflammation, American Academy of neurology, 2021, 8 (4), pp.e1003. ⟨10.1212/NXI.0000000000001003⟩
Neurology Neuroimmunology & Neuroinflammation, 2021, 8 (4), pp.e1003. ⟨10.1212/NXI.0000000000001003⟩
Scientia
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Neurology® Neuroimmunology & Neuroinflammation
article-version (Version of Record) 3
ObjectivesThe study aimed to assess the potential for serum neurofilament light chain (NFL) levels to predict the risk of progressive multifocal leukoencephalopathy (PML) in natalizumab (NTZ)-treated patients with multiple sclerosis (MS) and to discr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd7e556e5e596930706054f15c466294
https://doi.org/10.1212/nxi.0000000000001003
https://doi.org/10.1212/nxi.0000000000001003